CytoAgents is a biotechnology company focused on the development of innovative pharmaceutical products for the treatment of influenza and other viral infectious diseases. Using a novel, host-directed approach, CytoAgents targets the underlying cause of life- threatening symptoms associated with influenza and cytokine release syndrome by modulating the natural immune response to the disease.